Location: Sydney, Australia
Macquarie University PhD scholarships in Medical Statistics
(see attached ad, commencing February 2006)
Applications due: 16 December, 2005
(late applications and applications for later starting dates will be
considered).
Dear Colleagues,
Applications are called for a PhD scholarship for biostatistical/
methodological research relevant to clinical trials advertised
(attached htm) by Macquarie University on Wednesday 30/11/05 (Australian
HES).
Projects contribute to the NHMRC Program Grant research of the Centre
for Clinical Trials, University of Sydney. Applications are due by 16
December, 2005.
Preferred project topic areas are provided on the page
http://www.ctc.usyd.edu.au/research/research.htm
In particular, see topics: Patterns of outcomes after Myocardial
Infarction; Multiple event Markov modelling;
Robust inference using saddle-point approximation.
This scholarship offers a non-taxable stipend., with top
ups to AUD $28,247 per annum for outstanding applicants, for three years
full-time study commencing in 2006. In addition there are generous
operating and training allowances up to $5,000 p.a.
With best wishes for Christmas.
Malcolm Hudson
[log in to unmask]
####################################################################################################################
IMPORTANT NOTICE: This e-mail and any attachment to it are intended only to be read or used by the named addressee.
It is confidential and may contain legally privileged information. No confidentiality or privilege is waived or lost
by any mistaken transmission to you. The CTC is not responsible for any unauthorised alterations to this e-mail or
attachment to it. Views expressed in this message are those of the individual sender, and are not necessarily the
views of the CTC. If you receive this e-mail in error, please immediately delete it and notify the sender. You must
not disclose, copy or use any part of this e-mail if you are not the intended recipient.
#####################################################################################################################
|